Skip to content

Mansoor Ahmed

NPI 1366154742ActiveIndividual· Internal Medicine, Nephrology· Stony Brook, NY

Internal Medicine, Nephrology in Stony Brook, New York, licensed in NY, with an NPI issued in December 2022. Part D covered 22 prescriptions written in 2024, 95% of them generic. Calliditas Therapeutics US Inc. reported $36.94 in payments in 2025, mostly food and beverage.

Overview

NPI1366154742
StatusActive
Entity typeIndividual
Sole proprietorYes
NPI issuedDec 19, 2022
Last updated in NPPESDec 19, 2022
Certified by providerDec 17, 2022

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Nephrology Primary207RN0300X000000NY

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)22 · 24 30-day fills
Total drug cost$1,134
Generic share95% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$36.94 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Calliditas Therapeutics US Inc.$36.941

What the 2025 payments were for

  • Food and Beverage$36.94 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other nephrologists in Stony Brook

All 16 nephrologists in Stony Brook · All nephrologists in New York